Question 1

How many shares of CDTX does UBS Group AG own?

Accepted Answer

UBS Group AG previously held 0 shares of CDTX (CIDARA THERAPEUTICS INC) before exiting the position in 2026-Q1.

Question 2

What is UBS Group AG's CDTX position worth?

Accepted Answer

UBS Group AG's CDTX position was last reported at $0 in 2026-Q1 before the exit.

Question 3

Is UBS Group AG buying or selling CDTX?

Accepted Answer

In 2026-Q1, UBS Group AG exited their CDTX position entirely (-100.0% change in shares).

Question 4

When did UBS Group AG first buy CDTX?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in CDTX in 2024-Q3. They have held the position across 24 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$221.38	0
2025-Q4	Increased	1.1M	+127.0%	$237.4M	0.0%	$220.80	50
2025-Q3	Increased	473,554	+166.2%	$45.3M	0.0%	$95.26	47
2025-Q2	Increased	177,910	+166.3%	$8.7M	0.0%	$49.45	44
2025-Q1	Increased	66,813	+42.5%	$1.4M	0.0%	$22.39	34
2024-Q4	Increased	46,871	+697.5%	$1.3M	0.0%	$25.25	41
2024-Q3	Increased	5,877	+300.6%	$63,178	0.0%	$10.74	23

CDTXShowing 7 of 24 quarters

CDTX
Showing 7 of 24 quarters